Ask us any clinical question 👩🏻‍⚕️🏥🧑🏽‍⚕️and we’ll send you an evidence-based response.🚀💊💉
Joined June 2013
- Tweets 1,736
- Following 394
- Followers 466
- Likes 115
340 Photos and videos
🎗️ October is Breast Cancer Awareness Month 🎗️
In recognition of this, we will be releasing daily one-pagers this week, featuring educational literature on breast cancer.
Stay tuned for updates!
#breastcancerawareness #evidencebased #stayinformedwithInpharmD
#MedTwitter
1
141
This month, the following drugs were approved by the U.S Food and Drug Administration (FDA).
Read our clinical summaries on new approvals here:
inpharmd.com/blogs
#stayinformedwithInpharmD #druginformation #evidencebased #MedTwitter
1
1
109
Exciting news! InpharmD is launching an AI Expert Series where pharmacy leaders will discuss AI's role in clinical and health system pharmacy. Stay tuned, more details to come!
#stayinformedwithInpharmD #AIinPharmacy #druginformation #evidencebased #MedTwitter
3
80
For our next testimonial, we had the pleasure to chat with Dr. Isha Rana, Associate Director of Ambulatory Pharmacy at Mount Sinai Health System!
We're thrilled that to help clinical teams drive evidence-based care!
#stayinformedwithinpharmd #evidencebasedmedicine #MedTwitter
1
252
Have you heard our latest Evidence Based Medicine (EBM) podcast? Tune in as we discuss the SURMOUNT-OSA trials assessing tirzepatide for sleep apnea:
Spotify: open.spotify.com/episode/105…
Apple: podcasts.apple.com/us/podcas…
#druginformation #evidencebasedmedicine #MedTwitter
1
2
108
Read InpharmD's clinical summaries on newly approved FDA medications for the month of July:
AHZANTIVE® (aflibercept-mrbb) inpharmd.com/blogs/new-fda-a……
PYZCHIVA® (ustekinumab-ttwe) inpharmd.com/blogs/new-fda-a……
#MedTwitter #StayInformedWithInpharmD #DrugInformation #Evidencebased
1
1
105
KISUNLA™ (donanemab-azbt)
inpharmd.com/blogs/new-fda-a…
EPYSQLI™(eculizumab-aagh)
inpharmd.com/blogs/new-fda-a…
FEMLYV™ (ethinyl estradiol and norethindrone acetate)
inpharmd.com/blogs/new-fda-a…
1
144
We have four new FDA approval updates this week! Read the InpharmD summaries on our blog.
1. Capvaxive™ - inpharmd.com/blogs/new-fda-a…
2. Vigafyde™ - inpharmd.com/blogs/new-fda-a…
3. Yimmugo® - inpharmd.com/blogs/new-fda-a…
4. Sofdra™ - inpharmd.com/blogs/new-fda-a…
#MedTwitter #StayInpharmD
1
2
105
Single-dose rasburicase with frequent laboratory monitoring is effective in the management of TLS and offers significant cost reductions.
Read full response here: inpharmd.com/inquiries/15520
#MedTwitter #DrugInformation
68
The FDA recently approved mRESVIA, an mRNA RSV vaccine, to protect adults aged 60 years and older from lower respiratory tract disease.
Read the InpharmD summary here: inpharmd.com/blogs/new-fda-a…
#druginformation #evidencebasedmedicine #newdrugapproval #MedTwitter
79
Have you listened to our latest podcast? In this episode, we talk about excoriation (skin-picking) disorder and potential treatment options.
Spotify – open.spotify.com/episode/0yd…
Apple – podcasts.apple.com/us/podcas…
#pharmacypodcast #druginformation #medtwitter #evidencebasedcare
77
The FDA recently approved BKEMV™, the first biosimilar referencing Soliris (eculizumab) for treating paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Read InpharmD's summary below:
inpharmd.com/blogs/new-fda-a…
#druginformation #MedTwitter
1
351
The FDA recently approved YESAFILI™(aflibercept-jbvf) and OPUVIZ™(aflibercept-yszy) as interchangeable biosimilars to Eylea (aflibercept).
Read InpharmD's clinical summary here: inpharmd.com/blogs/new-fda-a…
#druginformation #evidencebased #MedTwitter
92
In the adult population, lacosamide appears to be both safe and tolerable as an IV push at dosages up to 400 mg, with bradycardia not being a significant side effect.
Read the full InpharmD inquiry here: inpharmd.com/inquiries/3b8d0…
#druginfo #evidencebased #pharmacy #MedTwitter
83
The FDA recently approved IMDELLTRA™ (tarlatamab-dlle), a bispecific T-cell engager (BiTE) for the treatment of small cell lung cancer (SCLC) that has progressed on or after platinum-based chemotherapy.
Read InpharmD's summary: inpharmd.com/blogs/new-fda-a…
#MedTwitter #DrugInfo
1
1
123
MYHIBBIN™, an oral liquid formulation of mycophenolate mofetil, is indicated to prevent organ rejection in adults and children (3 months ) with kidney, heart, or liver transplants.
Learn more here:inpharmd.com/blogs/new-fda-a…
#druginformation #evidencebased #MedTwitter
72
Case reports indicate that symptoms of rash presented over 2 to 7 days after methylphenidate administration in majority of patients
Read InpharmD's DI response here: inpharmd.com/inquiries/496d5…
#druginformation
#evidencebased
#MedTwitter
86